AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 21734423 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxorubicin-eluting SAP microspheres
Number of subjects: 30
Study 21734423 — intervention group
Group type: COMPARATOR
Intervention: Conventional TACE (control group)
Number of subjects: 30
Study 18443391 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted psychiatric intervention conducted by a psychiatric liaison nurse and/or referral to a liaison psychiatrist, followed by advice to the treating physician or organization of a multidisciplinary case conference.
Number of subjects: 247
Study 18443391 — intervention group
Group type: COMPARATOR
Intervention: Care as usual
Number of subjects: 247
Study 18443391 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted psychiatric intervention
Number of subjects: 247
Study 16809729 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfimeprase 3.0 mg
Number of subjects: 55
Study 16809729 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfimeprase 1.0 mg
Number of subjects: 55
Study 16809729 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfimeprase 0.3 mg
Number of subjects: 55
Study 16809729 — intervention group
Group type: COMPARATOR
Intervention: Alteplase 2.0 mg
Number of subjects: 55
Study 14663215 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (25 mg)
Number of subjects: 0
Study 14663215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10800630 — intervention group
Group type: COMPARATOR
Intervention: Tetrazepam-ratiopharm film-coated tablets (test preparation)
Number of subjects: 20
Study 10800630 — intervention group
Group type: COMPARATOR
Intervention: Tablets of a reference preparation (reference preparation)
Number of subjects: 20
Study 8653995 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine 100 mg for 14 days
Number of subjects: 21
Study 1458567 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-Fluorouracil (5-FU) at 330 mg/m2 per week for colorectal cancer (167 mg/m2 daily for the first 3 months), Adriamycin (ADR) at 20 mg/m2 every 4 weeks, and mitomycin C (MMC) at 2.7 mg/m2 every 2 weeks for gastric cancer. 5-FU at 1,000 mg/m2 every week for 19 colorectal cancer patients.
Number of subjects: 84
Study 1458567 — intervention group
Group type: EXPERIMENTAL
Intervention: Implantable port system for repeated hepatic arterial infusion chemotherapy.
Number of subjects: 84
Study 6718925 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominantly horizontal EOG activity
Number of subjects: 0
Study 6718925 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominantly vertical EOG activity
Number of subjects: 0
Study 6718925 — intervention group
Group type: COMPARATOR
Intervention: Dream narratives and corresponding EOG recordings
Number of subjects: 0
Study 30963404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary dragon fruit peel powder (DFPP) at levels of 0, 1, 2, 3, and 4% of the substrate
Number of subjects: 0
Study 30963404 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary dragon fruit peel powder (DFPP)
Number of subjects: 0
Study 27613551 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonically Activated Shears (UAS)
Number of subjects: 56
Study 27613551 — intervention group
Group type: COMPARATOR
Intervention: Conventional Monopolar Electrocautery (CME)
Number of subjects: 56
Study 26002770 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (100 mg)
Number of subjects: 16500
Study 26002770 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16500
Study 25168405 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic tube potential selection (ATPS)
Number of subjects: 325
Study 25168405 — intervention group
Group type: COMPARATOR
Intervention: Control group (constant current of 120 kV)
Number of subjects: 325
Study 22325086 — intervention group
Group type: EXPERIMENTAL
Intervention: Valsartan add-on treatment
Number of subjects: 3031
Study 22325086 — intervention group
Group type: COMPARATOR
Intervention: Non-ARB treatment
Number of subjects: 3031
Study 19548410 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.8-mm-diameter abutments (test group)
Number of subjects: 22
Study 19548410 — intervention group
Group type: COMPARATOR
Intervention: 5.5-mm-diameter abutments (control group)
Number of subjects: 22
Study 17542340 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 0.15 microg/kg/wk
Number of subjects: 0
Study 17542340 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 0.30 microg/kg/wk
Number of subjects: 0
Study 17542340 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. 0.60 microg/kg/wk
Number of subjects: 0
Study 17542340 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. (all doses)
Number of subjects: 0
Study 17542340 — intervention group
Group type: EXPERIMENTAL
Intervention: C.E.R.A. (0.60 microg/kg)
Number of subjects: 0
Study 14716711 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone monotherapy (4.2 mg/day)
Number of subjects: 96
Study 11826488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrullin
Number of subjects: 0
Study 11826488 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrullin in combination with VPN
Number of subjects: 0
Study 9552059 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal methotrexate and cranial radiotherapy (CRTX)
Number of subjects: 24
Study 9552059 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose intravenous methotrexate with folinic acid rescue and continuing intrathecal methotrexate (HDMTX)
Number of subjects: 24
Study 9552059 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuing intrathecal methotrexate alone (ITMTX)
Number of subjects: 24
Study 9552059 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups (ITMTX, HDMTX, CRTX)
Number of subjects: 24
Study 8141113 — intervention group
Group type: EXPERIMENTAL
Intervention: Central nervous system prophylaxis (intrathecal methotrexate plus cranial irradiation)
Number of subjects: 62
Study 8141113 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 62
Study 3048935 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin, 2 gm, given three times in a period of 10 hours.
Number of subjects: 352
Study 3048935 — intervention group
Group type: COMPARATOR
Intervention: Ampicillin, 1 gm, four times daily, and metronidazole, 0.5 gm, three times daily, for 72 hours.
Number of subjects: 352
Study 29030873 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin
Number of subjects: 48
Study 29030873 — intervention group
Group type: COMPARATOR
Intervention: Doxycycline
Number of subjects: 48
Study 27002117 — intervention group
Group type: EXPERIMENTAL
Intervention: VTD (bortezomib-thalidomide-dexamethasone)
Number of subjects: 340
Study 27002117 — intervention group
Group type: COMPARATOR
Intervention: VCD (bortezomib-cyclophosphamide-dexamethasone)
Number of subjects: 340
Study 25686304 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindful Awareness Practices (MAPs) intervention
Number of subjects: 49
Study 25686304 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene Education (SHE) intervention
Number of subjects: 49
Study 25686304 — intervention group
Group type: EXPERIMENTAL
Intervention: Both MAPs and SHE interventions
Number of subjects: 49
Study 23211454 — intervention group
Group type: EXPERIMENTAL
Intervention: Lavender and Tea tree oils (group T) applied twice a day for 3 months
Number of subjects: 24
Study 23211454 — intervention group
Group type: COMPARATOR
Intervention: Placebo (group P) applied twice a day for 3 months
Number of subjects: 24
Study 20809169 — intervention group
Group type: EXPERIMENTAL
Intervention: Resected popliteus tendon (Group A)
Number of subjects: 18
Study 20809169 — intervention group
Group type: COMPARATOR
Intervention: Intact popliteus tendon (Group B)
Number of subjects: 18
Study 20809169 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro study with transected popliteus tendon
Number of subjects: 18
Study 20809169 — intervention group
Group type: COMPARATOR
Intervention: In vitro study with intact popliteus tendon
Number of subjects: 18
Study 17301736 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (400 mg/day for 3 days)
Number of subjects: 12
Study 15390234 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous injection of ascorbate
Number of subjects: 34
Study 15390234 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 34
Study 22076584 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-prepared intra-arterial flush solutions with longer hang times
Number of subjects: 0
Study 22076584 — intervention group
Group type: COMPARATOR
Intervention: Nurse-prepared intra-arterial flush solutions
Number of subjects: 0
Study 9849048 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronary dipyridamole (0.5 mg/kg body weight)
Number of subjects: 763
Study 9849048 — intervention group
Group type: COMPARATOR
Intervention: Conventional pretreatment (heparin 15000 IE, aspirin 500 mg i.v.)
Number of subjects: 763
Study 7973073 — intervention group
Group type: EXPERIMENTAL
Intervention: Bandwidth knowledge of results (KR) conditions
Number of subjects: 0
Study 7973073 — intervention group
Group type: COMPARATOR
Intervention: Specific knowledge of results (KR) conditions
Number of subjects: 0
Study 2526009 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus of 400 mg teicoplanin 1, 3, 6 or 12 h prior to surgery
Number of subjects: 24
Study 1097143 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride (20 mg/day)
Number of subjects: 8
Study 1097143 — intervention group
Group type: COMPARATOR
Intervention: Frusemide (80 mg/day)
Number of subjects: 8
Study 1097143 — intervention group
Group type: COMPARATOR
Intervention: Chlorothiazide (1000 mg/day)
Number of subjects: 8
Study 1097143 — intervention group
Group type: COMPARATOR
Intervention: Chlorothiazide, Frusemide, Ethacrynic acid
Number of subjects: 8
Study 29331692 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavior Therapy (CBT)
Number of subjects: 32
Study 29331692 — intervention group
Group type: COMPARATOR
Intervention: Supportive Psychotherapy (SP)
Number of subjects: 32
Study 28407660 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium, 200 IU Vitamin D, and 90 µg Vitamin K supplementation
Number of subjects: 55
Study 26081230 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-piece aspheric IOL (Tecnis ZA9003, AMO)
Number of subjects: 49
Study 26081230 — intervention group
Group type: COMPARATOR
Intervention: 1-piece aspheric IOL (Tecnis ZCB00, AMO)
Number of subjects: 49
Study 23494570 — intervention group
Group type: EXPERIMENTAL
Intervention: Mexican PROGRESA/Oportunidades program (Conditional Cash Transfer program)
Number of subjects: 0
Study 23494570 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21441068 — intervention group
Group type: EXPERIMENTAL
Intervention: Community based resistance training
Number of subjects: 49
Study 21441068 — intervention group
Group type: COMPARATOR
Intervention: Flexibility training
Number of subjects: 49
Study 18502381 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovascular aneurysm repair (EVAR)
Number of subjects: 2
Study 18502381 — intervention group
Group type: COMPARATOR
Intervention: Open repair
Number of subjects: 2
Study 16596861 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led education and self-help
Number of subjects: 0
Study 16596861 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and motivational interview
Number of subjects: 0
Study 16596861 — intervention group
Group type: EXPERIMENTAL
Intervention: Audit and recall
Number of subjects: 0
Study 16596861 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary prevention
Number of subjects: 0
Study 15248139 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 (12-15 MIU/d) + ART
Number of subjects: 30
Study 15248139 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 (6 MIU/d) + ART
Number of subjects: 30
Study 15248139 — intervention group
Group type: COMPARATOR
Intervention: ART alone
Number of subjects: 30
Study 15248139 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 30
Study 11473880 — intervention group
Group type: EXPERIMENTAL
Intervention: Lumbar epidural anesthesia (LEA) with lidocaine
Number of subjects: 19
Study 11473880 — intervention group
Group type: EXPERIMENTAL
Intervention: General anesthesia (GA) with thiopental and isoflurane
Number of subjects: 19
Study 11473880 — intervention group
Group type: COMPARATOR
Intervention: No anesthesia (Control)
Number of subjects: 19
Study 9735687 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral staple lung volume reduction surgery
Number of subjects: 300
Study 9735687 — intervention group
Group type: COMPARATOR
Intervention: Unilateral staple lung volume reduction surgery
Number of subjects: 300
Study 9735687 — intervention group
Group type: COMPARATOR
Intervention: Unilateral laser surgery
Number of subjects: 300
Study 9735687 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery overall
Number of subjects: 300
Study 9735687 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung volume reduction surgery
Number of subjects: 300
Study 8041983 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous perfusion of lidocaine 2% (group CP)
Number of subjects: 31
Study 8041983 — intervention group
Group type: COMPARATOR
Intervention: Bolus administration of lidocaine 2% (group B)
Number of subjects: 31
Study 2648150 — intervention group
Group type: EXPERIMENTAL
Intervention: Surfactant (100 mg of phospholipid per kilogram of body weight [4 ml per kilogram])
Number of subjects: 159
Study 2648150 — intervention group
Group type: COMPARATOR
Intervention: Air placebo (4 ml per kilogram)
Number of subjects: 159
Study 4825114 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin prophylaxis (5,000 IU mucous heparin sodium given two hours preoperatively and for five days post operatively)
Number of subjects: 300
Study 4825114 — intervention group
Group type: COMPARATOR
Intervention: Unheparinized group
Number of subjects: 300
Study 4825114 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose heparin prophylaxis
Number of subjects: 300
Study 31430484 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 3 mg
Number of subjects: 40
Study 31430484 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivastigmine 6 mg
Number of subjects: 40
Study 31430484 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 31430484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocaine administration on day 10
Number of subjects: 40
Study 28410818 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol group received initial and additional doses of rocuronium (0.6 mg.kg−1 and 10 mg, respectively); blockade reversal with neostigmine (50 μg.kg−1); time ≥ 15 minutes between reversion and extubation.
Number of subjects: 122
Study 28410818 — intervention group
Group type: COMPARATOR
Intervention: Control group received initial and additional doses of rocuronium, blockade reversal, neostigmine dose, and extubation time at the discretion of the anesthesiologist.
Number of subjects: 122
Study 28410818 — intervention group
Group type: COMPARATOR
Intervention: Control group (patients with PORC)
Number of subjects: 122
Study 28410818 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol group (with PORC vs. without PORC)
Number of subjects: 122
Study 28410818 — intervention group
Group type: EXPERIMENTAL
Intervention: Entire study population (with PORC vs. without PORC)
Number of subjects: 122
Study 24803523 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical dose of esmolol
Number of subjects: 3
Study 24803523 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 3
Study 24803523 — intervention group
Group type: EXPERIMENTAL
Intervention: Esmolol-treated groups (both clinical and subclinical doses)
Number of subjects: 3
Study 23474997 — intervention group
Group type: EXPERIMENTAL
Intervention: Taekwondo training for 1 hour daily over three months
Number of subjects: 44
Study 23474997 — intervention group
Group type: COMPARATOR
Intervention: DCD control group (no training)
Number of subjects: 44
Study 21459745 — intervention group
Group type: EXPERIMENTAL
Intervention: High levels of family contact
Number of subjects: 180
Study 21459745 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate levels of family contact
Number of subjects: 180
Study 21459745 — intervention group
Group type: COMPARATOR
Intervention: Low levels of family contact
Number of subjects: 180
Study 19627690 — intervention group
Group type: EXPERIMENTAL
Intervention: ESCAPE‐knee pain
Number of subjects: 64
Study 19627690 — intervention group
Group type: COMPARATOR
Intervention: Outpatient physiotherapy
Number of subjects: 64
Study 16685298 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorhexidine rinse twice daily with 15 ml for 30 seconds for one week before and one week after surgery (group I)
Number of subjects: 99
Study 16685298 — intervention group
Group type: COMPARATOR
Intervention: Chlorhexidine rinse twice daily with 15 ml for 30 seconds for one week after surgery (group II)
Number of subjects: 99
Study 15374554 — intervention group
Group type: EXPERIMENTAL
Intervention: PAXpress
Number of subjects: 70
Study 15374554 — intervention group
Group type: COMPARATOR
Intervention: Laryngeal Mask Airway (LMA)
Number of subjects: 70
Study 11389117 — intervention group
Group type: EXPERIMENTAL
Intervention: Meropenem
Number of subjects: 342
Study 11389117 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime
Number of subjects: 342
Study 9431832 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone 1000 microg day-1 (F1000)
Number of subjects: 10
Study 9431832 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled fluticasone 2000 microg day-1 (F2000)
Number of subjects: 10
Study 9431832 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisolone 50 mg (PRED)
Number of subjects: 10
Study 9431832 — intervention group
Group type: COMPARATOR
Intervention: Inhaled placebo (PL)
Number of subjects: 10
Study 8099863 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg isamoltane
Number of subjects: 15
Study 8099863 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg isamoltane
Number of subjects: 15
Study 8099863 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (20 mg)
Number of subjects: 15
Study 8099863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 3545744 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mg Nisoldipine
Number of subjects: 60
Study 3545744 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg Nisoldipine
Number of subjects: 60
Study 3545744 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg Nisoldipine
Number of subjects: 60
Study 3545744 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31987238 — intervention group
Group type: EXPERIMENTAL
Intervention: NutraforChol® (red yeast rice extract, guggulipid extract, chromium picolinate)
Number of subjects: 0
Study 31987238 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 31987238 — intervention group
Group type: EXPERIMENTAL
Intervention: NutraforChol®
Number of subjects: 0
Study 31000333 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise training (ET) added to a post-discharge disease management program (DMP)
Number of subjects: 278
Study 30577818 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC) by fathers for one hour every day until discharge
Number of subjects: 50
Study 30577818 — intervention group
Group type: COMPARATOR
Intervention: Traditional care (TC)
Number of subjects: 50
Study 30577818 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin-to-skin contact (SSC)
Number of subjects: 50
Study 26886716 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E (400 IU/day)
Number of subjects: 83
Study 26886716 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study 24444117 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate administered in the prehospital setting
Number of subjects: 0
Study 24444117 — intervention group
Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 0
Study 21924644 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioral survey analysis
Number of subjects: 820
Study 19708473 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory Integrative (SI) therapy
Number of subjects: 120
Study 19708473 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceptual‐motor (PM) approach
Number of subjects: 120
Study 19708473 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurodevelopmental treatment (NDT)
Number of subjects: 120
Study 19708473 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120
Study 18457248 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral immune nutrition (EIN)
Number of subjects: 20
Study 18457248 — intervention group
Group type: COMPARATOR
Intervention: Standard enteral formula (EN)
Number of subjects: 20
Study 15745668 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief intervention (motivational intervention)
Number of subjects: 126
Study 15745668 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (simple advice)
Number of subjects: 126
Study 12229307 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 80 mg daily for three days
Number of subjects: 22
Study 12229307 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 9637641 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric bupivacaine
Number of subjects: 80
Study 9637641 — intervention group
Group type: COMPARATOR
Intervention: Hyperbaric bupivacaine
Number of subjects: 80
Study 9637641 — intervention group
Group type: EXPERIMENTAL
Intervention: Isobaric or hyperbaric bupivacaine
Number of subjects: 80
Study 7915989 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (DX)
Number of subjects: 31
Study 7915989 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP)
Number of subjects: 31
Study 7915989 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose methylprednisolone (LDMP)
Number of subjects: 31
Study 2643500 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparin sodium 10 units/mL
Number of subjects: 147
Study 2643500 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride injection
Number of subjects: 147
Study 4443869 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous phototherapy for 5 days
Number of subjects: 120
Study 4443869 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent phototherapy (12 hr on and 12 hr off) for 5 days
Number of subjects: 120